PMC:7283670 / 99250-99387 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7283670","sourcedb":"PMC","sourceid":"7283670","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7283670","text":"Various combination of protease inhibitors, oseltamivir, favipiravir, and chloroquin for treatment of covid19: a randomized control trial","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T798","span":{"begin":111,"end":112},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T798","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T462","span":{"begin":23,"end":42},"obj":"Chemical"},{"id":"T464","span":{"begin":32,"end":42},"obj":"Chemical"},{"id":"T465","span":{"begin":44,"end":55},"obj":"Chemical"},{"id":"T466","span":{"begin":57,"end":68},"obj":"Chemical"}],"attributes":[{"id":"A462","pred":"chebi_id","subj":"T462","obj":"http://purl.obolibrary.org/obo/CHEBI_37670"},{"id":"A463","pred":"chebi_id","subj":"T462","obj":"http://purl.obolibrary.org/obo/CHEBI_60258"},{"id":"A464","pred":"chebi_id","subj":"T464","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A465","pred":"chebi_id","subj":"T465","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A466","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_134722"},{"subj":"T462","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T464","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T465","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T466","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#93ecb4","default":true},{"id":"LitCovid-PD-CHEBI","color":"#ec9a93"}]}]}}